Espié M - Search Results

1

Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial.

Cortés J, Dieras V, Ro J, Barriere J, Bachelot T, Hurvitz S, Le Rhun E, Espié M, Kim SB, Schneeweiss A, Sohn JH, Nabholtz JM, Kellokumpu-Lehtinen PL, Taguchi J, Piacentini F, Ciruelos E, Bono P, Ould-Kaci M, Roux F, Joensuu H. Cortés J, et al. Among authors: espie m. Lancet Oncol. 2015 Dec;16(16):1700-10. doi: 10.1016/S1470-2045(15)00373-3. Epub 2015 Nov 17. Lancet Oncol. 2015. PMID: 26596672 Clinical Trial.

2

A review of the antitumour activity of vinorelbine in breast cancer.

Marty M, Extra JM, Dieras V, Giacchetti S, Ohana S, Espié M. Marty M, et al. Among authors: espie m. Drugs. 1992;44 Suppl 4:29-35; discussion 66-9. doi: 10.2165/00003495-199200444-00004. Drugs. 1992. PMID: 1283848 Review.

3

5HT3-antagonist receptors: their role in drug-induced emesis.

Dieras V, Extra JM, Le Bonniec M, Madelaine I, Espie M, Marty M. Dieras V, et al. Among authors: espie m. Nouv Rev Fr Hematol (1978). 1990;32(6):449-52. Nouv Rev Fr Hematol (1978). 1990. PMID: 1983228 Review.

4

[Fundamental and methodologic bases of therapeutic intensification].

Marty M, Extra JM, Dieras V, Espie M. Marty M, et al. Among authors: espie m. Pathol Biol (Paris). 1989 Nov;37(9):961-4. Pathol Biol (Paris). 1989. PMID: 2608350 French. No abstract available.

5

Megestrol acetate in advanced breast carcinoma.

Espie M. Espie M. Oncology. 1994 Oct;51 Suppl 1:8-12. doi: 10.1159/000227408. Oncology. 1994. PMID: 7970508

6

[Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast].

Culine S, Extra JM, Espie M, Bourstyn E, Dieras V, Giacchetti S, Maylin C, De Rocquancourt A, Morvan F, Marty M. Culine S, et al. Among authors: espie m. Bull Cancer. 1993 Nov;80(11):994-1000. Bull Cancer. 1993. PMID: 8081037 French.

7

Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method.

Dieras V, Extra JM, Bellissant E, Espie M, Morvan F, Pierga JY, Mignot L, Tresca P, Marty M. Dieras V, et al. Among authors: espie m. J Clin Oncol. 1996 Dec;14(12):3097-104. doi: 10.1200/JCO.1996.14.12.3097. J Clin Oncol. 1996. PMID: 8955654 Clinical Trial.

8

Prospects with docetaxel in the treatment of patients with breast cancer.

Marty M, Extra JM, Cottu PH, Espié M. Marty M, et al. Among authors: espie m. Eur J Cancer. 1997 Aug;33 Suppl 7:S26-9. doi: 10.1016/s0959-8049(97)90007-1. Eur J Cancer. 1997. PMID: 9486101 Review.

9

[Treatment of breast cancer].

Espié M. Espié M. Presse Med. 1998 Sep 12;27(26):1332-5. Presse Med. 1998. PMID: 9779053 Review. French.

10

Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.

Ardavanis A, Extra JM, Espié M, Cuvier C, Marty M. Ardavanis A, et al. Among authors: espie m. In Vivo. 1998 Sep-Oct;12(5):559-62. In Vivo. 1998. PMID: 9827368 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters